These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Influence of Comorbidity and Obesity on the Occurrence of Vascular Events in Obstructive Apnoea Treated with CPAP. Jurado-Robles I; Jurado-Gámez B; Feu Collado N; Molina-Luque R; Molina-Recio G Nutrients; 2024 Sep; 16(18):. PubMed ID: 39339671 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of catheter ablation of atrial fibrillation in patients with obstructive sleep apnoea with and without continuous positive airway pressure treatment: a meta-analysis of observational studies. Li L; Wang ZW; Li J; Ge X; Guo LZ; Wang Y; Guo WH; Jiang CX; Ma CS Europace; 2014 Sep; 16(9):1309-14. PubMed ID: 24696222 [TBL] [Abstract][Full Text] [Related]
6. Obstructive sleep apnoea and comorbidity - an overview of the association and impact of continuous positive airway pressure therapy. McNicholas WT Expert Rev Respir Med; 2019 Mar; 13(3):251-261. PubMed ID: 30691323 [TBL] [Abstract][Full Text] [Related]
7. Prevalence and treatment of central sleep apnoea emerging after initiation of continuous positive airway pressure in patients with obstructive sleep apnoea without evidence of heart failure. Westhoff M; Arzt M; Litterst P Sleep Breath; 2012 Mar; 16(1):71-8. PubMed ID: 21347650 [TBL] [Abstract][Full Text] [Related]
8. Effects of continuous positive airway pressure therapy on glycaemic control, insulin sensitivity and body mass index in patients with obstructive sleep apnoea and type 2 diabetes: a systematic review and meta-analysis. Feng Y; Zhang Z; Dong ZZ NPJ Prim Care Respir Med; 2015 Feb; 25():15005. PubMed ID: 25719929 [TBL] [Abstract][Full Text] [Related]
14. Obstructive sleep apnea is an independent risk factor for severe COVID-19: a population-based study. Rögnvaldsson KG; Eyþórsson ES; Emilsson ÖI; Eysteinsdóttir B; Pálsson R; Gottfreðsson M; Guðmundsson G; Steingrímsson V Sleep; 2022 Mar; 45(3):. PubMed ID: 34791469 [TBL] [Abstract][Full Text] [Related]
15. Obstructive sleep apnea: a cardiometabolic risk in obesity and the metabolic syndrome. Drager LF; Togeiro SM; Polotsky VY; Lorenzi-Filho G J Am Coll Cardiol; 2013 Aug; 62(7):569-76. PubMed ID: 23770180 [TBL] [Abstract][Full Text] [Related]
16. Obstructive sleep apnoea and Type 2 diabetes mellitus: are they connected? Mok Y; Tan CW; Wong HS; How CH; Tan KL; Hsu PP Singapore Med J; 2017 Apr; 58(4):179-183. PubMed ID: 28429032 [TBL] [Abstract][Full Text] [Related]
17. Association of clinically significant obstructive sleep apnoea with risks of contracting COVID-19 and serious COVID-19 complications: a retrospective population-based study of health administrative data. Kendzerska T; Povitz M; Gershon AS; Ryan CM; Talarico R; Franco Avecilla DA; Robillard R; Ayas NT; Pendharkar SR Thorax; 2023 Sep; 78(9):933-941. PubMed ID: 36717242 [TBL] [Abstract][Full Text] [Related]
18. Is obstructive sleep apnea a risk factor for diabetes? Clarenbach CF; West SD; Kohler M Discov Med; 2011 Jul; 12(62):17-24. PubMed ID: 21794205 [TBL] [Abstract][Full Text] [Related]
19. Does Continuous Positive Airway Pressure (CPAP) treatment of obstructive sleep apnoea (OSA) improve asthma-related clinical outcomes in patients with co-existing conditions?- A systematic review. Davies SE; Bishopp A; Wharton S; Turner AM; Mansur AH Respir Med; 2018 Oct; 143():18-30. PubMed ID: 30261988 [TBL] [Abstract][Full Text] [Related]
20. Sleep apnoea is a risk factor for severe COVID-19. Strausz S; Kiiskinen T; Broberg M; Ruotsalainen S; Koskela J; Bachour A; ; Palotie A; Palotie T; Ripatti S; Ollila HM BMJ Open Respir Res; 2021 Jan; 8(1):. PubMed ID: 33436406 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]